某综合医院多重耐药菌感染状况与变化趋势
[Abstract]:OBJECTIVE: To detect MDRO infection and colonization in time by monitoring the cases of MDRO infection, analyze the current status and trend of MDRO infection, and explore the possible causes, so as to identify the key population for MDRO prevention and control, so as to better control the production and spread of MDRO. METHODS: From 2013 to 2016, full-time staff and practitioners from hospital infection were selected. Laboratory staff found MDO strains in hospitalized patients daily through the Hospital Laboratory Information System (LIS) and removed duplicate samples from the same patient. The MDO monitored included multidrug/pan-drug resistant Acinetobacter baumannii (MDR/PDR-AB), methicillin-resistant Staphylococcus aureus (MRSA), multidrug/pan-resistant Pseudomonas aeruginosa. MDR / PDR - PA, Vancomycin - resistant Enterococcus (VRE), Carbapenem - resistant Enterobacteriaceae (CRE). In 2013, after the detection of MDRO strains in hospitalized patients, hospital infection staff only used the telephone as the only way to inform the patient's ward to take disinfection and isolation measures against the corresponding patients, and to improve the case In addition to monitoring MDRO cases in 2014, 2015 and 2016, interventions were also taken, including implementation of disinfection and isolation, implementation of hand hygiene, and training of MDRO knowledge. Strengthen the management of key links, rationalize the use of antibiotics, and carry out the "Plan-Do-Check-Correct Action" (PDCA) quality continuous improvement measures year by year. Adopt descriptive epidemiological methods to analyze the MDRO infection status and change trend in 2013, 2014, 2015 and 2016. In 2016, 546 cases of MDRO nosocomial infection were monitored. The incidence of MDRO nosocomial infection in four years was 0.24, 0.24, 0.21, 0.18, decreasing year by year from 2013 to 2016. The difference was statistically significant (2 trends C = 25.829, P 0.001). In four years, 1273 cases of MDRO were monitored. The detection rate of MDRO in four years was 4.30%, from 2013 to 2016. The detection rates of MRSA, MDR/PDR-PA decreased year by year (2 trends C = 6.554, P 0.05). The detection rates of CRE increased year by year (2 trends C = 51.719, 21.154, P 0.001). There was no significant difference between the detection rates of VRE and MDR/PDR-AB. The incidence of nosocomial infection of MDRO in ICU, Cadre and Burn Departments declined year by year from 2013 to 2014. The difference was statistically significant (2 trends C were 27.270, 9.503, 10.338, P were 0.01). Neurosurgery, transplantation, otorhinolaryngology, orthopedics, hematology, renal diseases There was no significant difference in the incidence of MDRO nosocomial infections in the following day among the departments of transplantation, thoracic surgery and other departments (P 0.05). The ICU was the most common one in the four years, followed by transplantation and neurosurgery. The incidence and detection rate of MDRO nosocomial infection in the first quarter were 0.36 and 4.46%, respectively. The lowest in the fourth quarter was 0.19 and 3.44%, respectively. The difference was statistically significant (c2 = 38.945, 12.442, P 0.01). The number of MDRO nosocomial infection cases in the first quarter accounted for the detection rate. The proportion of MDRO cases and nosocomial infections was the highest, and the lowest in the fourth quarter.4.In the four years, the main pathogens were MDR/PDR-AB (35.27% and 40.84%) and MRSA (40.14% and 28.57%). The infection cases accounted for the highest proportion of MDRO cases, 69.23%, MRSA lowest, 30.53%. 5. MDRO nosocomial infection system was mainly respiratory system (71.25%), followed by digestive system (12.45%), blood system, urinary system, etc. MRSA main infection sites were respiratory system, skin and soft tissue; MDR / PDR - AB, MDR / PDR - PA, CRE main infection sites. The major infection sites of VRE were the digestive system and urinary system. In the past four years, the source of MDRO samples was the respiratory tract, followed by skin secretion and urine. In the past four years, the consumption of hand washing fluid was 4.90, 7.64, 10.86, 11.43 ml / bed day, and the consumption of quick-drying hand disinfectant was 1.77, respectively. Consumption of hand sanitizer, quick-drying hand disinfectant and toilet paper was negatively correlated with the incidence of MDRO nosocomial infection (correlation coefficients r were - 0.971, - 0.953, - 0.969, P were 0.05). Conclusion: The consumption of MDRO from 2013 to 2016 was negatively correlated with the incidence of MDRO nosocomial infection. The incidence and detection rate of nosocomial infections are decreasing year by year, which may be related to a series of interventions including the implementation of disinfection and isolation measures, strict hand hygiene of medical staff, and the increasing consumption of hand sanitizer, quick-drying hand disinfectant and hand wiping paper. Targeted prevention and control.
【学位授予单位】:天津医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R446.5
【参考文献】
相关期刊论文 前10条
1 漆坚;;临床分离多重耐药菌的分布及变化趋势[J];实验与检验医学;2016年05期
2 黎日海;刘建瑜;吴甲文;;某院多重耐药菌检出率及耐药性分析[J];中国临床新医学;2016年07期
3 顾克菊;沈永红;;实施主动筛查防控重症监护病房多重耐药菌传播流行[J];中国感染控制杂志;2016年06期
4 周静;陶丽;张立萍;薛宏;王朝静;;连续4年多重耐药菌医院感染监测及干预效果评价[J];中国消毒学杂志;2016年04期
5 梅雪飞;荚恒敏;张亮;杨会志;范恒梅;谢少清;;综合干预措施对ICU患者呼吸道多重耐药菌感染/定植的防控效果[J];中国感染控制杂志;2016年03期
6 陈玉华;曾翠;龚瑞娥;冯丽;吴红曼;刘珍如;任南;文细毛;吴安华;;某三级甲等综合医院多药耐药菌监测与预防控制研究[J];中华医院感染学杂志;2016年01期
7 吴淑梅;黄小兰;任泽娟;;集束化管理策略在多重耐药菌管理中的应用[J];中国感染控制杂志;2015年12期
8 宋洲洋;齐秀英;;某综合医院多重耐药菌监测及干预效果分析[J];现代预防医学;2015年24期
9 胡付品;朱德妹;汪复;蒋晓飞;徐英春;张小江;张朝霞;季萍;谢轶;康梅;王传清;王爱敏;徐元宏;沈继录;孙自镛;陈中举;倪语星;孙景勇;褚云卓;田素飞;胡志东;李金;俞云松;林洁;单斌;杜艳;韩艳秋;郭素芳;魏莲花;吴玲;张泓;孔菁;胡云建;艾效曼;卓超;苏丹虹;;2014年CHINET中国细菌耐药性监测[J];中国感染与化疗杂志;2015年05期
10 陈美恋;贾会学;李六亿;;多重耐药菌感染监测及防控现状综述[J];中国感染控制杂志;2015年08期
相关硕士学位论文 前1条
1 邓琼;医院感染血液中肺炎克雷伯菌的分子流行病学及其耐碳青霉烯类抗菌药物危险因素调查[D];南昌大学;2014年
,本文编号:2215006
本文链接:https://www.wllwen.com/linchuangyixuelunwen/2215006.html